Companies: 10,795·Total market cap: $144.5T
Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc.

CPRXNASDAQHealthcare● Active
$31.28
+$0.01(+0.03%)
Market Cap$3.8B
P/E Ratio—
52W High$32.56
52W Low$19.05
Cash on HandFinancialsRevenue

Catalyst Pharmaceuticals, Inc. (CPRX) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

CPRX · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$709.2M▲ +37.0% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$709.2M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+37.0%
vs prior fiscal year
Latest Quarter
$755.9M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$709.2MCash on Hand
Total Debt$2.8MTotal Debt
Net Cash / Net Debt+$706.4MNet Cash Position
Cash vs Debt Ratio
Cash 100%Debt 0%

Catalyst Pharmaceuticals, Inc. has a net cash position of $706.4M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$709.2M − $2.8M = +$706.4M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
CPRX annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$709.2M+37.0%
Dec 31, 2024$517.6M+276.0%
Dec 31, 2023$137.6M-53.9%
Dec 31, 2022$298.4M+56.0%
Dec 31, 2021$191.3M+36.3%
CPRX cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc.YOU
CPRX
$709.2M18.5%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Catalyst Pharmaceuticals, Inc. (CPRX) cash on hand as of December 31, 2025 is $709.2M, comprising $709.2M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Catalyst Pharmaceuticals, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Catalyst Pharmaceuticals, Inc. cash reserves or cash position.

Catalyst Pharmaceuticals, Inc. annual cash on hand history shows increased +37.0% in 2025: increased +37.0% in 2025. Catalyst Pharmaceuticals, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Catalyst Pharmaceuticals, Inc. carries total debt of $2.8M against cash of $709.2M, resulting in a net cash position of +$706.4M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

CPRX cash on hand · 5 questions

As of December 31, 2025, Catalyst Pharmaceuticals, Inc. (CPRX) has $709,171,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $709,171,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $755,859,000. Data sourced from the annual 10-K filing via FMP.

CPRX cash on handCPRX cash reservesCPRX cash 2025how much cash does CPRX have

▸ Source: FMP /balance-sheet-statement · US GAAP · Catalyst Pharmaceuticals, Inc. · Catalyst Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025